Brent Sabatini
Förmögenhet: 677 208 $ per 2026-08-31
Förmögenhet: 677 208 $ per 2026-08-31
Brent Sabatini is Senior VP, Chief Financial & Accounting Officer at Vir Biotechnology, Inc. since 2026.
Formerly, Mr. Sabatini was Head-Finance at Capsida Biotherapeutics, Inc. from 2021 to 2023.
Education includes an MBA from Stephen M.
Ross School of Business and an undergraduate degree from The California State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC. 0,04 % | 2026-06-01 | 61 902 ( 0,04 % ) | 677 208 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Finansdirektör/CFO | 2026-08-03 |
| Företag | Position | Slut |
|---|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Företagsledare/Principal | 2023-02-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån